Evofem Biosciences Q3 EPS $(0.3) Beats $(0.31) Estimate

Evofem Biosciences (NASDAQ:EVFM) reported quarterly losses of $(0.3) per share which beat the analyst consensus estimate of $(0.31) by 3.23 percent. This is a 57.75 percent increase over losses of $(0.71) per share from

Benzinga · 11/06/2019 21:57

Evofem Biosciences (NASDAQ:EVFM) reported quarterly losses of $(0.3) per share which beat the analyst consensus estimate of $(0.31) by 3.23 percent. This is a 57.75 percent increase over losses of $(0.71) per share from the same period last year.